ANÁLOGOS DO PEPTÍDIO INTESTINAL VASOATIVO

摘要

The present invention comprises a VPAC-2 receptor agonist of the formula (I): or a pharmaceutically acceptable salt thereof. Underlined residues indicate a side-chain to side-chain covalent linkage of the first and last amino acids within the segment. The present invention also encompasses pharmaceutical compositions containing such agonists, and the use of such agonists for the treatment of pulmonary diseases including COPD.